Barrigel - Radiotherapy protection spacer

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Prieinama:

Palette Life Sciences Australia Pty Ltd

Klasė:

Class III

Pagaminta:

Palette Life Sciences 27 E Cota Street Suite 402, Santa Barbara, CA, 93101 United States Of America

Gydymo sritis:

60424 - Radiotherapy protection spacer

Terapinės indikacijos:

Barrigel is a sterile, transparent, biodegradable gel of stabilized hyaluronic acid of non-animal origin, supplied in a glass syringe. Barrigel acts by adding volume to the tissue, thereby mechanically creating an increased distance between the prostate and the anterior rectal wall. The product degrades over time. Barrigel is used to increase the distance between the prostate and the anterior rectal wall, with the intent to decrease radiation dose delivered to the rectum when treating prostate cancer with radiation.

Autorizacija statusas:

A

Leidimo data:

2020-07-21